Understanding the Etiopathogenesis of Non-Arteritic Anterior Ischemic Optic Neuropathy with Laboratory Findings

Basit Öğe Kaydı
dc.contributor.authorUzakgider, Neslisah Kutlu
dc.contributor.authorAdiyeke, Seda Karaca
dc.contributor.authorAytogan, Hasan
dc.date.accessioned2025-03-20T09:45:01Z
dc.date.available2025-03-20T09:45:01Z
dc.date.issued2024
dc.departmentİzmir Bakırçay Üniversitesi
dc.description.abstractObjectives: The role of inflammation and hemostasis in non-arteritic anterior ischemic optic neuropathy (NAION) was investigated by examining related blood tests. The predictive values of these laboratory indicators and their effects on prognosis were reviewed. Methods: In this study, 48 patients diagnosed with NAION and 50 healthy volunteers were included. All subjects underwent full ophthalmological examination. All patients were treated with oral corticosteroids (methylprednisolone 1 mg/kg/ day) for 15 days after that corticosteroid medication was reduced and stopped. Each patient was monitored at least for 12 months. The mean platelet volume (MPV), platelet distribution width (PDW), neutrophil/lymphocyte ratio (NLR), and red cell distribution width (RDW) values were recorded. These findings were compared with control group. Results: The mean MPV, RDW, and NLR values were significantly higher in NAION group (respectively, p<0.001, p=0.006, and p<0.001). There was no statistically significant difference between group 1 and group 2 in PDW values, but the mean PDW value was higher in the patient group compared to the control group (p=0.435). Based on the receiver operating characteristic (ROC) curve, the NLR had the strongest predictive value. This was followed by MPV, RDW, and PDW with lower diagnostic predictive values. Conclusion: MPV, NLR, and RDW were found to be elevated and have diagnostic predictive values in NAION patients. Easily accessible and simple laboratory methods could help us show systemic inflammation and ischemic events in NAION patients. As a result, inflammatory reactions besides ischemic changes may play a role in the etiopathogenesis of NAION. These biomarkers can be evaluated to ensure that patients with risk factors for the development of NAION. © 2024 Kare Publishing. All rights reserved.
dc.identifier.doi10.14744/bej.2023.09815
dc.identifier.endpage13
dc.identifier.issn2459-1777
dc.identifier.issue1
dc.identifier.scopus2-s2.0-85187671586
dc.identifier.scopusqualityQ4
dc.identifier.startpage8
dc.identifier.trdizinid1273681
dc.identifier.urihttps://doi.org/10.14744/bej.2023.09815
dc.identifier.urihttps://search.trdizin.gov.tr/tr/yayin/detay/1273681
dc.identifier.urihttps://hdl.handle.net/20.500.14034/2125
dc.identifier.volume9
dc.indekslendigikaynakScopus
dc.indekslendigikaynakTR-Dizin
dc.language.isoen
dc.publisherKare Publishing
dc.relation.ispartofBeyoglu Eye Journal
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_Scopus_20250319
dc.subjectMean platelet volume
dc.subjectneutrophil/lymphocyte ratio
dc.subjectnon-arteritic ischemic optic neuropathy
dc.subjectplatelet distribution width
dc.subjectred cell distribution width
dc.titleUnderstanding the Etiopathogenesis of Non-Arteritic Anterior Ischemic Optic Neuropathy with Laboratory Findings
dc.typeArticle

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu
TR-Dizin İndeksli Yayınlar Koleksiyonu